Clinical Trials Logo

Emotions clinical trials

View clinical trials related to Emotions.

Filter by:

NCT ID: NCT02737761 Completed - Clinical trials for Congestive Heart Failure

Researching Emotions And Cardiac Health

REACH
Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to understand how positive emotions (e.g., optimism, happiness) are associated with health behavior adherence in patients with heart failure (HF), as well as whether performing exercises to improve positive emotions may help to improve health behavior adherence as well.

NCT ID: NCT02509559 Completed - Emotions Clinical Trials

Effects of Propranolol (vs. Placebo) on Information Processing During Presentation of Emotionally Arousing Pictures

BBEmoMem_G
Start date: October 2013
Phase: Phase 1
Study type: Interventional

The main objective of the present study is to combine two lines of research, investigating the interaction between emotional processing and memory performance (on both behavioral and electrophysiological levels) and its modulation by ß-blockade. Concerning pharmacological manipulations with ß-blockers, there are no studies, which investigated the effects of propranolol on electrophysiological (ERPs) and behavioral measures of recognition memory along with their codependence on individual variations of adrenergic receptors' polymorphisms. Till now, also the findings about genetic influences of ADRB1 and ADRB2 on recognition memory for emotional contents are lacking. Therefore, the current investigation has been designed to replicate the former results which revealed reduced ERP correlates of recognition memory for emotional pictures due to administration of ß-blocker propranolol. Furthermore investigators goal is to test, whether there are any differences between carriers of genetic variants of the ADRB1 and ADRB2 in memory performance and/or changes in event-related potentials and in propranolol influences on the above mentioned processes. In conclusion, investigators hypothesize: (1) a memory advantage of emotionally arousing stimuli over emotionally neutral pictures; (2) more pronounced ERP components (EPN, LPP, old-new effect) associated with encoding and memory for emotional stimuli; (3) a reduction of electrocortical correlates of emotional recognition memory (old-new effect) caused by propranolol; (4) a potential impact of genetic variants of the ADRB1 and ADRB2 on the emotional information processing and memory formation alone, and on the propranolol modulation of those processes. Furthermore, investigators hypothesize additional pharmacodynamic effects of propranolol such as influence on skin- conductance, pulse waves, burdening heart frequency, pulmonary function and metabolomics, which might depend on the ADRB1 and ADRB2 genotype.

NCT ID: NCT02499406 Completed - Suicidal Ideation Clinical Trials

Dialectical Behavior Therapy Skills Group Pilot Evaluation

Start date: December 2014
Phase: N/A
Study type: Interventional

Uncontrolled pilot study examines feasibility, acceptability, and preliminary efficacy of Dialectical Behavior Therapy skills group for Veterans with suicidal ideation and emotion dysregulation.

NCT ID: NCT01909895 Completed - Clinical trials for Endothelial Dysfunction

Study of the Effects of Negative Emotions on Endothelial Function

PUME
Start date: September 1, 2013
Phase: N/A
Study type: Interventional

Study aims and hypotheses are as follows: Primary Hypotheses: Compared to the neutral condition, the anger recall task will acutely induce endothelial dysfunction by impairing endothelium-dependent arterial vasodilation (Hypothesis 1a); increasing circulating levels of EC-derived microparticles (EMPs), a marker of EC injury (Hypothesis 1b); and reducing circulating levels of bone marrow-derived endothelial progenitor cells (EPCs), a marker of EC reparative capacity (Hypothesis 1c). Secondary Hypotheses: Compared to the neutral condition, the depressed mood and separately the anxiety recall tasks will acutely impair endothelium-dependent arterial vasodilation, increase circulating levels of EMPs, and reduce circulating levels of bone marrow-derived EPCs. There will be a relation of the level of self-reported anger, depressed mood, and anxiety with endothelial dysfunction.

NCT ID: NCT01807442 Completed - Clinical trials for Acute Coronary Syndrome

Positive Psychology to Improve Cardiac Health Behaviors

PEACE
Start date: March 2013
Phase: N/A
Study type: Interventional

The purpose of the study is to understand peoples' positive emotions, like how optimistic or grateful they feel, after they have had a heart problem. The investigators want to determine whether positive emotions affect peoples' ability to follow recommendations, like following a healthy diet, exercising, and taking medication.

NCT ID: NCT01806701 Completed - Emotions Clinical Trials

Brain Response to Treatment for Pediatric PTSD

Start date: April 2013
Phase: N/A
Study type: Interventional

This study will examine how brain activation changes as a result of behavioral treatment for posttraumatic stress disorder (PTSD) in adolescents. The investigators will conduct functional magnetic resonance imaging (fMRI) scans before and after the widely-used trauma-focused cognitive behavioral therapy to better understand how the brain recovers from illness. This study will provide much needed information about brain abnormalities in abused youth, and could lead to improvements in behavioral treatments for patients who do not respond to current treatments.

NCT ID: NCT01786083 Completed - Anxiety Clinical Trials

Caring for Family Caregivers:a Research-action Study

Start date: September 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of the Problem Solving Technique (PST) in reducing symptoms of anxiety and depression among primary caregivers of chronically ill patients. And also to describe and evaluate the process carried out by nurses when implementing the PST as a useful tool for care for family caregivers.

NCT ID: NCT01778582 Completed - Emotions Clinical Trials

Perspective-taking, and Examining the Clinical Trial Informed Consent Process

Start date: November 15, 2012
Phase:
Study type: Observational

Background: - Very few people with cancer participate in clinical trials. Some are uncertain about the treatment, or are afraid of being treated like a guinea pig. They may also feel that they have inadequate information about the trial. One possible way of encouraging people to sign up for clinical trials is to improve the informed consent process. Researchers want to understand how people read and understand informed consent documents. Objectives: - To study perspective taking, and to study how people understand the information and enrollment process for a clinical trial. Eligibility: - Healthy volunteers at least 18 years of age. Design: - This study will require one study visit. - Participants will watch one of four movie clips. They will be asked to respond to the film by looking at it from the main character s perspective. They will then answer questions about how the clips made them feel. - Participants will read a sample cancer clinical trial consent form on a computer. The computer will record their eye movements while they read the text. They will then be asked whether they remember the information in the consent form, and whether they would participate in the trial. - No treatment will be provided as part of this study.

NCT ID: NCT01668771 Completed - Alcohol Drinking Clinical Trials

Self-Affirmation and Response to Health Risk Information

Start date: August 11, 2012
Phase:
Study type: Observational

Background: - Self-affirmation is the process of reflecting on values that a person considers important. This process may encourage people to be more open to information about health risks. It may also encourage them to change their behaviors or lifestyle to decrease these health risks. Researchers want to look at the effect of self-affirmation on people s responses to new health risk information. Because recent studies have linked alcohol consumption to increased risk of breast cancer, the study will focus on alcohol s link to breast cancer. Objectives: - To study how self-affirmation can change opinions following a message about a health risk. Eligibility: - Women at least 18 years of age who drink at least two alcoholic beverages per week and/or at least three alcoholic beverages per sitting. Design: - Participants will be recruited through an online panel. The study will be conducted entirely online. - Participants will respond to two short studies. The first will ask about life events and how they make people feel. The second will look at how people respond to information about alcohol and breast cancer. - For the first study, participants will write a paragraph or two about an important event in their lives. They will answer questions about how that event made them feel. They will also write a paragraph about an important personal value. - For the second study, participants will read information about alcohol and breast cancer risk. They will then answer questions about this information. They will also answer questions about their beliefs about alcohol and breast cancer. - Participants will receive financial compensation for being in this study.

NCT ID: NCT01629069 Completed - Behavior Clinical Trials

A Transplant or Cancer Resilience Intervention

Start date: September 2012
Phase: N/A
Study type: Interventional

The overall aim of this protocol is to examine patient and care-giver outcomes and acceptance of a new 6 week intervention in Arizona for our transplant and cancer patients and their care-givers, designed to improve quality of life, decrease perceived stress, and improve medical outcomes, that has been approved as a pilot clinical program at Mayo Clinic in Arizona.